NCT05056311

Brief Summary

Reconstructive surgery is advocated for most children with hypospadias, a condition in which the pee hold is not in the correct place on the penis, to prevent potentially serious cosmetic and functional problems. Parents faced with a decision about hypospadias repair encounter an irreversible choice with potentially lifelong consequences. Recent studies have identified decisional conflict (DC) and decisional regret (DR) as a significant problem for parents. Several recent guidelines on complex urologic topics suggest that shared decision-making (SDM) is the optimal approach. A pilot test of a decision aid website by parents potentially facing this decision will be conducted to measure pre- and post-outcomes, in order to develop a fuller understanding of how urologists can effectively provide parents with optimal decision support. Parents will answer questions via phone up to four time points, twice before (T1 and T2) and twice after seeing a urologist for a hypospadias referral (T3 and T4). If the urologist diagnoses hypospadias but recommends no surgery, the final data collection point will be three months after the urology visit. If the urologist recommends repair surgery, the final data collection point will be six months after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 9, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 24, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2022

Completed
11 months until next milestone

Results Posted

Study results publicly available

August 30, 2023

Completed
Last Updated

August 30, 2023

Status Verified

July 1, 2023

Enrollment Period

1.3 years

First QC Date

August 31, 2021

Results QC Date

August 2, 2023

Last Update Submit

August 2, 2023

Conditions

Keywords

hypospadiasshared decision makingdecisional regretdecision aid

Outcome Measures

Primary Outcomes (4)

  • Percent of Eligible Parents Screened (Feasibility)

    Recruitment is defined as the number of potential participants who are eligible divided by the total number screened multiplied by 100.

    Baseline (T1)

  • Percent of Eligible Parents Enrolled (Feasibility)

    The number of parents enrolled divided by the total number of parents who were eligible multiplied by 100.

    Baseline (T1)

  • Decision Aid Acceptability by Categories of Information, Length, Clarity, and Balance (Acceptability)

    Acceptability of a decision aid refers to ratings regarding the comprehensibility of components of a decision aid, its length, clarity, amount of information, and balance in presentation of information about options. The tool has 4 questions with answers on a Likert scale ranging from 1-5 (length, amount of information, and balance) and 1-4 (clarity). A response of 3 is ideal for information, length, and balance and a response of 1 is ideal for clarity.

    Pre-consultation, 1 week after baseline (T2)

  • Percentage of Parents Retained in the Study (Feasibility)

    Number of parents who completed the study divided by the number of eligible parents enrolled who completed the study multiplied by 100.

    T1 to T4, a total of approximately 6 months

Secondary Outcomes (10)

  • Mean Decisional Conflict Scale (DCS) Score at T1 and T2

    Baseline (T1), Pre-consultation, 1 week after baseline (T2)

  • Mean Decisional Conflict Scale (DCS) Score at T2 and T3

    Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)

  • Mean Decision-Specific Knowledge Scores

    Baseline (T1), Pre-consultation, 1 week after baseline (T2)

  • Mean Decisional Regret Scale Score

    3-month post-consultation (T4)

  • Hypospadias Treatment Preference by Category at T1 and T2

    Baseline (T1), Pre-consultation, 1 week after baseline (T2)

  • +5 more secondary outcomes

Study Arms (1)

Parent Utilization of Decision Aid Website

EXPERIMENTAL

All enrolled parents will view the decision aid website for as long and as frequently as they wish before the initial visit to the urologist.

Other: Decision Aid Website

Interventions

The (private) decision aid website contains information in text, graphic, and video form about hypospadias and considerations for choosing surgery and no surgery.

Parent Utilization of Decision Aid Website

Eligibility Criteria

Age0 Years - 5 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • parents 18 years of age and older of sons with hypospadias, or a tentative hypospadias diagnosis, and/or referral to a urologist for hypospadias
  • patient newborn up to age 5 years
  • parent able to consent and do interview in English
  • parent access to a reliable internet and smart phone, tablet, or computer to view the website
  • child/patient scheduled to see a urologist, but must not have yet seen the urologist at the time of enrollment
  • parent aware that there is an issue with child's pee hole
  • parent planning to attend urology appointment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

UNC

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

Hypospadias

Condition Hierarchy (Ancestors)

Urogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPenile DiseasesGenital Diseases, MaleGenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Elaine Cuevas
Organization
Indiana University

Study Officials

  • Katherine Hubert Chan, MD, MPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2021

First Posted

September 24, 2021

Study Start

June 9, 2021

Primary Completion

October 6, 2022

Study Completion

October 6, 2022

Last Updated

August 30, 2023

Results First Posted

August 30, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations